Skip to Content
Merck
CN

857345P

Avanti

VPC 01091

Avanti Research - A Croda Brand

Synonym(s):

((1R,3S)-1-amino-3-(3-octylphenyl)cyclopentyl)methanol (hydrochloride salt)

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C20H34ClNO
CAS Number:
Molecular Weight:
339.94
UNSPSC Code:
12352211
NACRES:
NA.25
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

VPC 01091, Avanti Research - A Croda Brand 857345P, powder

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 1 mg (857345P-1mg)

manufacturer/tradename

Avanti Research - A Croda Brand 857345P

lipid type

phospholipids
bioactive lipids

shipped in

dry ice

storage temp.

−20°C

SMILES string

N[C@](C1)(CO)CC[C@@H]1C2=CC=C(CCCCCCCC)C=C2

General description

This product is covered by Patent Number US 7,754,703. Avanti manufactures this under license from University of Virginia.
VPC 01091 is a sphingosine analog.

Biochem/physiol Actions

VPC 01091 is a selective sphingosine 1-phosphate receptor-1 (S1PR1) agonist and sphingosine 1-phosphate receptor-3 (S1PR3) antagonist. It confers protection against lung injury and dysfunction after ischemia-reperfusion (IR) in mice.

Packaging

5 mL Amber Glass Screw Cap Vial (857345P-1mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Matthew L Stone et al.
American journal of physiology. Lung cellular and molecular physiology, 308(12), L1245-L1252 (2015-04-26)
Outcomes for lung transplantation are the worst of any solid organ, and ischemia-reperfusion injury (IRI) limits both short- and long-term outcomes. Presently no therapeutic agents are available to prevent IRI. Sphingosine 1-phosphate (S1P) modulates immune function through binding to a
Byoungjae Kong et al.
Nature communications, 10(1), 185-185 (2019-01-16)
Membrane-disrupting agents that selectively target virus versus host membranes could potentially inhibit a broad-spectrum of enveloped viruses, but currently such antivirals are lacking. Here, we develop a nanodisc incorporated with a decoy virus receptor that inhibits virus infection. Mechanistically, nanodiscs



Global Trade Item Number

SKUGTIN
857345P-1MG04061835191260